Crawford Investment Counsel Inc. decreased its position in Aetna Inc. (NYSE:AET) by 38.7% during the third quarter, Holdings Channel reports. The institutional investor owned 3,400 shares of the company’s stock after selling 2,150 shares during the period. Crawford Investment Counsel Inc.’s holdings in Aetna were worth $393,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of AET. Boston Advisors LLC acquired a new stake in Aetna during the second quarter worth $294,000. Cullen Frost Bankers Inc. increased its stake in Aetna by 2.9% in the second quarter. Cullen Frost Bankers Inc. now owns 2,572 shares of the company’s stock worth $314,000 after buying an additional 72 shares in the last quarter. PGGM Investments increased its stake in Aetna by 54.7% in the second quarter. PGGM Investments now owns 794,893 shares of the company’s stock worth $97,080,000 after buying an additional 280,978 shares in the last quarter. Genesee Valley Trust Co. acquired a new stake in Aetna during the second quarter worth $203,000. Finally, Pitcairn Co. increased its stake in Aetna by 1.1% in the second quarter. Pitcairn Co. now owns 5,229 shares of the company’s stock worth $639,000 after buying an additional 55 shares in the last quarter. Hedge funds and other institutional investors own 88.11% of the company’s stock.

Institutional Ownership by Quarter for Aetna (NYSE:AET)

Shares of Aetna Inc. (NYSE:AET) traded down 0.27% during mid-day trading on Friday, reaching $122.31. The company’s stock had a trading volume of 2,784,944 shares. The company has a 50-day moving average of $126.48 and a 200-day moving average of $118.82. The firm has a market cap of $42.92 billion, a PE ratio of 17.64 and a beta of 0.62. Aetna Inc. has a 12 month low of $92.42 and a 12 month high of $136.50.

Aetna (NYSE:AET) last released its earnings results on Thursday, October 27th. The company reported $2.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.02 by $0.05. The company had revenue of $15.78 billion for the quarter, compared to analyst estimates of $15.71 billion. Aetna had a return on equity of 16.25% and a net margin of 3.91%. Aetna’s quarterly revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm posted $1.90 EPS. On average, analysts predict that Aetna Inc. will post $8.02 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, January 27th. Stockholders of record on Thursday, January 12th will be issued a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a dividend yield of 0.82%. The ex-dividend date of this dividend is Tuesday, January 10th. Aetna’s dividend payout ratio (DPR) is currently 14.49%.

ILLEGAL ACTIVITY WARNING: “Crawford Investment Counsel Inc. Sells 2,150 Shares of Aetna Inc. (AET)” was posted by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally stolen and republished in violation of US and international copyright & trademark law. The correct version of this report can be read at http://www.dailypolitical.com/2017/01/13/crawford-investment-counsel-inc-sells-2150-shares-of-aetna-inc-aet.html.

A number of research firms have weighed in on AET. Zacks Investment Research upgraded shares of Aetna from a “sell” rating to a “hold” rating in a research note on Tuesday, November 22nd. Vetr downgraded shares of Aetna from a “buy” rating to a “hold” rating and set a $131.19 target price on the stock. in a research note on Tuesday, December 27th. Jefferies Group restated a “hold” rating and issued a $130.00 target price on shares of Aetna in a research note on Friday, December 16th. Cantor Fitzgerald restated a “buy” rating on shares of Aetna in a research note on Friday, December 23rd. Finally, Argus restated a “buy” rating and issued a $145.00 target price (up previously from $130.00) on shares of Aetna in a research note on Wednesday, December 28th. Nine research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. Aetna currently has a consensus rating of “Buy” and an average price target of $134.40.

Aetna Company Profile

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).

5 Day Chart for NYSE:AET

Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).

Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.